GLUT-1 has been shown to be associated with worse disease-specific mortality, overall survival, and tumor regression grade in some studies (12–15); others have reported statistically nonsignificant results (16–19), and one study reported a positive effect of GLUT-1 on overall survival (20). The gene discussed is SLC2A1; the disease is neoplasm.